Investor Gkcc, Llc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Gkcc, Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-06-04 13D/A ELTX / Elicio Therapeutics, Inc. 5,595,108 9,764,864
2024-09-27 13G XLO / Xilio Therapeutics, Inc. 7,000,000
2024-08-14 13D/A ELTX / Elicio Therapeutics, Inc. 2,152,767 5,595,108
2024-07-02 13D/A ELTX / Elicio Therapeutics, Inc. 2,043,180 2,152,767
2024-05-22 13G INKT / MiNK Therapeutics, Inc. 4,640,000
2024-03-20 13D/A ELTX / Elicio Therapeutics, Inc. 1,920,164 2,043,180
2023-12-26 13D/A ELTX / Elicio Therapeutics, Inc. 707,164 1,920,164
2023-09-22 13G NBIO / Nascent Biotech, Inc. 10,000,000
2023-08-30 13D IMMX / Immix Biopharma, Inc. 3,255,734
2023-06-14 13D ELTX / Elicio Therapeutics, Inc. 707,164